The ETERNAL project consortium's 5th General Assembly meeting in Barcelona on 24th and 25th October 2024 heard reports of continuing strong progress as the project's six industrial case study teams start to transition the focus of their work towards scale up for impact.

The application of digital technologies to the pharmaceutical industries has the potential to significantly increase the agility, efficiency and flexibility, the sustainability of the drug manufacturing processes, and the quality of the medicines produced. Despite all this, the pharmaceutical industry has been more hesitant to adopt digital technologies than other industries due to the complexities and expertise required in its development and manufacturing processes. However, with the growing demand for traditional and new drugs, there is a clear need for digitalization in the sector.